RADL3

/Raia Drogasil S.A.

HealthcareTax ID: 61.585.865/0001-51BRL

R$15.22-1.81%

Last update: --:--

Calculate Fair Price

Report (Preview)

Detailed and complete analysis about this company

This report is not an investment recommendation. It is a study of the company.

Access full B3 reports

Full analysis — RADL3 is available only for Premium subscribers.

With Premium you have access to detailed reports of all companies, with valuation and fair price.

Subscribe to Premium View plans

Price Chart

Data provided by TradingView

Loading chart...

Analyst Recommendations

Buy

Based on 15 analysts

Mean target price

$25.77

Potential

+69.3%

Min: $20.00•Max: $30.00

Valuation Multiples

Enterprise Value

R$34.55B

EV/EBITDA

8.95x

Fair

EV/Revenue

0.74x

Forward P/E

13.53x

Fair

P/S (Price/Sales)

0.57x

Current P/E

19.03x

Margins & Profitability

Gross Margin30.3%

Operating Margin7.6%

Net Margin2.9%

EBITDA Margin8.3%

ROA

7.8%

Return on Assets

ROE

20%

Return on Equity

Growth

Revenue Growth

(YoY)

↑+9.8%

Earnings Growth

(YoY)

↑+14.4%

Quarterly Earnings

(QoQ)

↑+13.5%

Corporate Risk

Beta

Volatility vs market

0.00

Less volatile

Dividends

Dividend Yield

2.96%

Payout Ratio

54.92%

Moderate Payout

Annual DY$0.45

Avg 5Y DY

1.09%+1.9 pp

Last Ex-DateOct 08, 2026

Moving Averages

50-day average

Short term

$19.48

↓ Below

200-day average

Long term

$20.70

↓ Below

Death Cross (bearish signal)

Average Volume

10 days

18.62M

3 months

12.6M

Trend+47.8%

Dividend History (12m)

Total last 12 months:R$0.45

Price Evolution (12m)

R$15.22-20.64%

Oct 25Last 12 monthsOct 26

Seasonality Study

Historical monthly performance of the asset over the last 11 years. Helps identify seasonal behavior patterns.

11 Years analyzed

Avg Return (%)

High Frequency (%)

Best Month

Jul+4.9%

2nd Best

Aug+3.8%

High Frequency

Jul70%

High Frequency

Aug70%

Balance Sheet

Period	Total Assets	Liabilities	Total Equity
2025	R$25.2B	R$17.8B	R$7.32B
2024	R$22.2B	R$15.7B	R$6.43B
2023	R$20.1B	R$14.1B	R$5.96B
2022	R$17.2B	R$11.8B	R$5.34B

MyHub Discussion (0)

About the Company

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

rdsaude.com.br

São Paulo, SP

Market Data

Market CapR$26.61B
Min 52sMax 52s
R$13.50R$27.42
Average Volume15.9M